Investors relieved at $572 million verdict in opioid trial; appeal planned

The Associated Press - August 27, 2019 2:29 pm

By The Associated Press

Johnson & Johnson investors exhaled in relief Tuesday, pushing up shares about 3 percent after an Oklahoma judge imposed a $572 million verdict late Monday for its role in the nation’s opioid crisis.

Investors had been holding their breath during a trial in which the state of Oklahoma, calling J&J a “kingpin” in the epidemic, sought up to $17 billion. The much-smaller verdict, and J&J’s immediate response that the verdict was “flawed” and it will appeal, reassured investors, for now.

“The risk of a loss was already baked into the stock price,” and this verdict doesn’t set a precedent for other cases, noted Erik Gordon, an analyst and professor at University of Michigan’s Ross School of Business.

 

Latest Stories

Biden Welcomes Trump Back to Oval Office in Traditional Power Transfer Ceremony

WASHINGTON (TNND) — President-elect Donald Trump traveled to Washington, D.C. Wednesday to meet with President Joe Biden...

Wildcat Jazz-Cats Jazz Ensemble and the Bella Voce Take the Stage

Enjoy a night of incredible music on Thursday, November 14 at 7:00 PM at the Concert...

Oklahoma Bets on Bitcoin Boom, Muskogee Locals Worry About Noise From Crypto Mining

OKLAHOMA CITY, Okla. (KOKH) — Oklahoma lawmakers are betting on bitcoin to bring more jobs to the...